Indonesia Medical Device Registration Services
Cisema provides strategic regulatory consulting for Indonesia medical device registration, supporting medical device and in-vitro diagnostic (IVD) manufacturers preparing for future market entry. We support early-stage planning, feasibility evaluations, and regulatory roadmap development for future registration with Indonesia’s Ministry of Health (MoH).
With deep insight into Indonesia’s evolving regulatory landscape and ASEAN harmonization frameworks, Cisema is your trusted partner for navigating the complexities of market entry planning.
What Sets Cisema Apart in Indonesia Medical Device Registration
Cisema’s Indonesia medical device registration services go beyond basic consulting. We deliver insight-driven support designed to strengthen regulatory preparedness:
Our team brings deep knowledge of Indonesia’s Ministry of Health regulations and submission procedures. We help you interpret and apply local requirements with precision and clarity.
We support your early-stage efforts with classification guidance, submission route analysis, and roadmap development tailored to your device profile and ASEAN goals.
We help integrate Indonesia into your broader Southeast Asia strategy, offering advice on CSDT harmonization and country-specific adaptations.
Our feasibility assessments and gap analyses uncover documentation risks and readiness gaps early—reducing downstream registration delays.
Our multilingual team provides clear communication and support across time zones — in Bahasa Indonesia, English, Mandarin, Cantonese, German, Spanish, French, Italian, Japanese and Korean.
We provide unbiased, preparatory guidance without commercial conflicts—ideal for companies planning entry but not yet ready to register.
Stay informed on regulatory changes, procedural shifts, and strategic developments through our real-time updates and advisory briefings.
Core Services for Indonesia Medical Device Registration
Planning for Indonesia medical device registration starts long before submission. Our core services turn regulatory complexity into a clear, actionable market entry strategy so you can move forward with confidence.
Regulatory Insight & Trends
Localized regulatory updates and tracking
- Monitor MoH announcements, decrees, and guidance
- Interpret risk classification rules and grouping guidance
- Summarize timelines and documentation scope by class
- Share regulatory updates that may impact Indonesia medical device approval
Actionable insight for global teams
- Provide device-specific regulatory overviews
- Clarify differences between ASEAN and Indonesian CSDT use
- Advise on future license holder and importer obligations
- Alert teams to procedural and system changes
Strategic Consultation & Planning
Custom market entry strategy
- Confirm product qualification as a medical device or IVD
- Recommend submission routes: standard or special access
- Advise on bundling and submission structuring
- Map classification and grouping logic across ASEAN
Market readiness and alignment
- Plan license holder and distributor roles for future phases
- Estimate review timelines and identify submission risks
- Integrate Indonesia into ASEAN rollout roadmaps
- Advise on importer relationships and logistics setup
Feasibility Review & Gap Analysis
Documentation readiness checks
- Review dossier structure against local CSDT formatting
- Identify missing technical files and inconsistencies
- Evaluate translation scope for Bahasa Indonesia content
- Align IFU, labeling, and claims with MoH requirements
Structured analysis and planning
- Deliver gap analysis with red-flag issues prioritized
- Provide a checklist based on ASEAN CSDT + MoH expectations
- Score document readiness and highlight priority areas
- Offer guidance on internal resource and timeline planning
Indonesia Medical Device Regulatory Framework
In the Indonesian medical device regulatory framework, Class A devices, classified as low-risk, are subject to a simplified registration process. While less stringent than higher classes, these devices must still comply with safety, labeling, and quality requirements set by the Ministry of Health. A valid distribution permit (Izin Edar) is required before marketing, and documentation must align with local and ASEAN CSDT standards.
| Country | Device Classes | LAR Required | Avg. Approval Timeline |
|---|---|---|---|
| Indonesia | Class A–D | Yes | 3 – 5 months |
Our Indonesia Medical Device Consultation Services are Ideal for Companies That:
- Need early regulatory intelligence before Indonesia medical device registration
- Are preparing long-term ASEAN expansion including Indonesia
- Want strategic advisory without committing to immediate product launch
- Require expert guidance on high-risk or combination devices
- Prefer building a foundation with a regionally connected regulatory partner
Why Partner with Cisema?
Proactive Planning for Future Market Entry
Start building your regulatory base in Indonesia now. With Cisema’s insight and advisory services, you can plan ahead confidently and avoid costly delays.
ASEAN-Aligned, Country-Specific Support
Indonesia is part of our integrated regional service network. While license holding is not yet available, our early-phase services ensure you’re prepared once formal registration begins.
Trusted Partner with Local & Regional Reach
Backed by over 20 years of global regulatory experience, Cisema delivers real-world insight, practical guidance, and multilingual support tailored to Indonesia’s evolving regulatory environment.
Key Data for Entering the Indonesia Medical Device Market
Indonesia is one of the fastest-growing medical device markets in Southeast Asia, supported by a large population, rising healthcare demand, and ongoing regulatory modernization. Below is a snapshot of essential data to support market entry planning and regulatory strategy.
| Data Category | Details |
|---|---|
| Market Size | Estimated USD 3.1 billion in 2022, projected to grow at 9% annually.[1] |
| Indonesia's Population | 277 million, with an aging demographic and increasing urbanization.[2] |
| Indonesia's Healthcare Facilities | Over 3,000 hospitals and 10,000+ public health centers.[3] |
| Key Regulatory Authorities | National Agency of Drug and Food Control (BPOM) and Ministry of Health. |
| Indonesia's Healthcare Expenditure | Approximately 3.2% of GDP.[4] |
| Indonesia's GDP | USD 1.39 trillion (2023).[5] |
[1] Indonesia Medical Device Market Report, Ministry of Industry.
[2] Badan Pusat Statistik (BPS), 2023 Population Data.
[3] Indonesia Ministry of Health, Health Facility Statistics.
[4] World Bank, Healthcare Expenditure Data for Indonesia.
[5] World Bank, Indonesia GDP 2023 Estimate.